4//SEC Filing
Hogue Dale Curtis Jr. 4
Accession 0000950170-24-001195
CIK 0001107421other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:30 PM ET
Size
7.8 KB
Accession
0000950170-24-001195
Insider Transaction Report
Form 4
Hogue Dale Curtis Jr.
DirectorSee Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2023-12-29+150,000→ 150,000 totalExercise: $0.07Exp: 2033-12-28→ Common Stock (150,000 underlying) - Award
Employee Stock Option (right to buy)
2023-12-29+41,667→ 41,667 totalExercise: $0.07Exp: 2033-12-28→ Common Stock (41,667 underlying)
Footnotes (2)
- [F1]One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date.
- [F2]In five equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date.
Documents
Issuer
Alaunos Therapeutics, Inc.
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0002006649
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:30 PM ET
- Size
- 7.8 KB